2169919-21-3(SNDX-5613)
2169919-21-3 Basic informationMore
- Product Name:SNDX-5613
- Synonyms: SNDX-5613 acute,Leukemia,inhibit,lymphoblastic,Epigenetic Reader Domain,Inhibitor,AML,Menin,ALL,SNDX 5613,SNDX-5613,SNDX5613,MLL,myeloid Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)- SNDX-5613 SNDX5613 Revumenib N-Ethyl-2-((4-(7-((trans-4-(ethylsulfonamido)cyclohexyl)methyl)-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl)oxy)-5-fluoro-N-isopropylbenzamide
- CAS:2169919-21-3
- MF:C32H47FN6O4S
- MW:630.82
- EINECS:
- Mol File:2169919-21-3.mol
-
Recommend You Select Member Companies
- Company Name:TargetMol Chemicals Inc.
- Tel:+1-781-999-5354 +1-00000000000
- Nationality:United States
- Products Intro:Product Name:SNDX-5613
CAS:2169919-21-3
Purity:98.00% Package:1 mg；10 mg；100 mg；200 mg；25 mg；5 mg；50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY - CB Index:58
- Related Information:Catalog(19892)
- Company Name:Aladdin Scientific
- Tel:+1-+1(833)-552-7181
- Nationality:United States
- Products Intro:Product Name:SNDX-5613
CAS:2169919-21-3
Purity:97% Package:$197.9/5mg;$345.9/10mg;$692.9/25mg;$1088.9/50mg;$1632.9/100mg;Bulk package Remarks:97% - CB Index:58
- Related Information:Catalog(57511)